🔎 Trials Near Me

Home › Alcohol Use Disorder (AUD) › NCT06302413

Enhancing Prospective Thinking in Early Recovery (HOME)

Recruiting

Enhancing Prospective Thinking in Early Recovery

Who can join

Ages 18 to 60 · All sexes

Full eligibility criteria
Inclusion Criteria:

* Abstinence between ≥14 days and ≤1 year
* Verbal endorsement of commitment to recovery
* Outpatient
* Psychotropic drugs for SUD-comorbidity
* Drug/alcohol abstinence ≥ 24 hours at the time of the study day visit
* English comprehension

Exclusion Criteria:

* Unstable medical disorders
* Habitual drug use
* Mu-opioid drugs
* Smell/taste disorders
* Unstable psychiatric conditions
* Extravagant/elaborate face tattoos

About the study

The goal of this clinical trial is to use a novel virtual reality intervention to test for efficacy in reducing alcohol use and increasing abstinence, with concomitant increases in future self-identification, future time perspective, and delay-of-reward, in early recovering alcohol use disorder (AUD) persons. The main question\[s\] this trial aims to answer are:

Will the Virtual Reality (VR) intervention decrease the number of stimulant use days? Will the VR intervention produce longer abstinence periods during follow-up visits? Will the VR intervention increase alcohol abstinence rates? Will the VR intervention increase future self-identification? Will the VR intervention increase self-reported future time perspective? Will the VR intervention increase preference for delayed rewards in a laboratory delay discounting task on the study day? Will the VR intervention produce gains in the behavioral effects of future self-identification, future time perspective, and delayed rewards at the 30-day and 6-month follow-ups? Researchers will compare the experimental and control groups to see if there are differences in the results for the questions outlined above.

What is being tested

Sponsor: Indiana University · Participants: 500 · Started: Feb 15, 2024

Contact the study team

Official record on ClinicalTrials.gov — NCT06302413

Locations in the U.S.

IndianaIndiana University School of Medicine - Goodman Hal, Indianapolis

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.